Your browser doesn't support javascript.
loading
[A Case of Advanced Esophageal Cancer with Esophago-Bronchial Fistula Closed by Pembrolizumab plus Chemotherapy Therapy].
Kondo, Yoshifumi; Aoki, Yoshiro; Morita, Hayato; Morita, Shunsuke; Shinbara, Kensuke; Honmyo, Naruhiko; Yano, Takuya; Nakagawa, Naoya; Adachi, Tomohiro; Kano, Mikihiro; Tokumoto, Noriaki; Kohashi, Toshihiko; Hihara, Jun; Mukaida, Hidenori.
Afiliação
  • Kondo Y; Dept. of Gastrointestinal Surgery, Hiroshima City North Medical Center Asa Citizens Hospital.
Gan To Kagaku Ryoho ; 50(5): 627-629, 2023 May.
Article em Ja | MEDLINE | ID: mdl-37218326
We report a case of unresectable advanced esophageal cancer with an esophageal fistula that was treated with pembrolizumab plus CDDP plus 5-FU therapy and the fistula was closed. A 73-year-old male was diagnosed with cervical-upper thoracic esophageal cancer and esophago-bronchial fistula on CT and esophagogastroduodenoscopy. He underwent chemotherapy containing pembrolizumab. The fistula was closed after 4 cycles and oral intake became possible. Six months have passed since the first visit and chemotherapy is ongoing. The prognosis of esophago-bronchial fistula is extremely poor, and there is no established treatment, including fistula closure. Chemotherapy containing immune checkpoint inhibitors could considered to be expected not only for local control but also for long-term survival.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Fístula Brônquica / Fístula Esofágica Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Aged / Humans / Male Idioma: Ja Ano de publicação: 2023 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Fístula Brônquica / Fístula Esofágica Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Aged / Humans / Male Idioma: Ja Ano de publicação: 2023 Tipo de documento: Article